Low-dose radiotherapy combined with neoadjuvant chemotherapy and an anti-PD-1/CTLA-4 bispecific antibody cardonilizumab for resectable locally advanced head and neck squamous cell carcinoma: Preliminary report of a single-arm, prospective phase II clinical study.

Authors: Zhijie Liu, Dong Wang, Muhua Yi, JianPeng Li, Zhutian Liu, Weiqi Chen, Zhiqiang Wang, Qinan Yang, Yumeng Huang, Zhigang Liu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18026

Source: Full article

---

Abstract

e18026